POST 00784E : MEASLES CAMPAIGN AND ITN DISTRIBUTION
Follow-up on Posts 00763E, 00765E, 00767E, 00768E, 00771E, 00774E, 00778E
and 00781E
1 May 2005
_____________________________________
Two further contributions to this discussion. The first is a second
contribution by Gerhard Hesse (mailto:[email protected])
from France. The second is from Thomas Teuscher (mailto:[email protected])
from the RBM Secretariat.
_____________________________________
Dear All,
Following this discussion for only a short time, but having attended the
Measles Partnership Meeting in Washington and being in discussion with some
country projects for mass re-treatments of existing nets, allow me some
comments from the "malaria" private sector point of view:
One of the points for the private sector to become interested in a new
emerging market is the aspect to achieve a sustainable market in the near
future, there is no difference for the health "market" than for others. A
second important aspect is the time for Return on the Investments (ROI)
made either to develop a new product, a new concept, to promote the
product, to hire new people etc.There is one opinion in the general
discussion saying that massive free distribution of nets does not creating
a sustainable market for ITNs, and is therefore not in the interest of the
private sector. On the other hand people like Larry Cassazza told me that
in some countries / districts it stimulated the local market heading than
towards sustainability. So here obviously the local aspect and the scope
have to be taken into consideration and one project does not look like the
other one. So massive free distribution can be in favor for the private
sector as I will elaborate later on.
For me an important point (which I never heard from someone else) is, that
once people have experienced a beneficial product like an ITN (lesser
bites, silent nights, and yes - lesser "Fever") they tend to continue using
it. Having achieved the coverage of the
Il n'y a pas encore de réponse à ce message.